ghk-cu bioavailability oral Repost from @skincareanarchy • Copper peptides are one of the most misunderstood Introducing GHK-CU — the science

View Study [2]"Safety, tolerability, pharmacokinetics, and pharmacodynamics of cagrilintide with semaglutide" Enebo LB et al., 2021 Finding: Phase 1b trial demonstrated that combining cagrilintide with semaglutide 2.4mg resulted in up to 17.1% weight loss at 20 weeks, with the combination being well-tolerated

Cuprizone-brain damage and motoric disability The used cuprizone regimen, several times higher than those regularly used in cuprizone studies (62), rapidly induced marked functional disability along with severely affected various brain areas

This approach appears to optimize results for targeted injury treatment

10.1007/s00401-009-0619-8 Acta Neuropathol